Leef Brands (LEEEF) Operating Expenses (2025 - 2026)
Leef Brands (LEEEF) posted Operating Expenses of $3.3 million for Q1 2026, down 16.07% sequentially from $4.0 million in Q1 2025, and down 16.07% YoY from $4.0 million in Q1 2025.
Leef Brands (LEEEF) Operating Expenses (2025 - 2026) Analysis & Trends
Leef Brands has reported Operating Expenses for 2 years, with the latest figure at $3.3 million in Q1 2026.
- Quarterly Operating Expenses fell 16.07% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (changed N/A YoY) and the FY2025 annual result came in at $18.1 million, up 15.36% from the prior year.
- Operating Expenses fell to $3.3 million in Q1 2026 per LEEEF's latest filing, from $4.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $4.0 million in Q1 2025 and troughed at $3.3 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Leef Brands | 59.45 Mn | 54.50 Mn | 2.41 Mn | 4.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.40 Mn |
| Mar 31, 2026 | 3.34 Mn |
| Mar 31, 2025 | 3.98 Mn |